Ad is loading...
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
WFEMX
Price
$14.69
Change
-$0.12 (-0.81%)
Updated
Nov 15 closing price
Ad is loading...

RNWFX vs WFEMX

Header iconRNWFX vs WFEMX Comparison
Open Charts RNWFX vs WFEMXBanner chart's image
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
WCM Focused Emerging Markets Investor
Price$14.69
Change-$0.12 (-0.81%)
VolumeN/A
CapitalizationN/A
RNWFX vs WFEMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWFX vs. WFEMX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Buy and WFEMX is a StrongSell.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. WFEMX (936M). RNWFX pays higher dividends than WFEMX: RNWFX (1.51) vs WFEMX (0.15). RNWFX was incepted earlier than WFEMX: RNWFX (23 years) vs WFEMX (11 years). WFEMX is a more actively managed with annual turnover of: 62.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than WFEMX: RNWFX (250) vs WFEMX (1000). WFEMX annual gain was more profitable for investors over the last year : 16.04 vs. RNWFX (11.54). RNWFX return over 5 years is better than : 17.17 vs. WFEMX (8.06).
RNWFXWFEMXRNWFX / WFEMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years11 years-
Gain YTD7.09910.86865%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B936M6,506%
Annual Yield % from dividends1.510.15996%
Returns for 1 year11.5416.0472%
Returns for 3 years-14.55-28.9250%
Returns for 5 years17.178.06213%
Returns for 10 years41.0046.9387%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics